Latest in Zepbound Mounjaro

Sort by

7 items

Lilly’s Mounjaro, Zepbound drugs see strong demand. So why did sales disappoint?

Eli Lilly’s stock heads for biggest selloff in more than three years after sales of anti-obesity drugs Mounjaro and Zepbound came up well short of forecasts.
Business - MarketWatch - 8 hours ago
Eli Lilly's Zepbound and Mounjaro are no longer in shortage. Here's where their sales still disappointed

Eli Lilly blamed the misses on drug wholesalers cutting inventory of Zepbound and Mounjaro.
Business - CNBC - 7 hours ago
Weight loss injections: How do drugs like Wegovy and Mounjaro work?

NHS experts report unprecedented demand for the new generation of obesity treatments.
Top stories - BBC News - October 18

Lilly’s Mounjaro, Zepbound drugs see strong demand. So why did sales disappoint?